Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 20/20 | 0.83 |
| ▸ | SMCHD1 | A6NHR9 | 1/20 | 0.83 |
| ▸ | MYO1G | B0I1T2 | 1/20 | 0.83 |
| ▸ | AIP | O00170 | 1/20 | 0.83 |
| ▸ | AP3B1 | O00203 | 1/20 | 0.83 |
| ▸ | PSMD11 | O00231 | 1/20 | 0.83 |
| ▸ | CDC7 | O00311 | 1/20 | 0.83 |
| ▸ | SAP18 | O00422 | 1/20 | 0.83 |
| ▸ | KPNA3 | O00505 | 1/20 | 0.83 |
| ▸ | PPP6C | O00743 | 1/20 | 0.83 |
| ▸ | TCERG1 | O14776 | 1/20 | 0.83 |
| ▸ | UBE2L6 | O14933 | 1/20 | 0.83 |
| ▸ | PPP1R12A | O14974 | 1/20 | 0.83 |
| ▸ | U2SURP | O15042 | 1/20 | 0.83 |
| ▸ | SETD1A | O15047 | 1/20 | 0.83 |
| ▸ | ARPC1B | O15143 | 1/20 | 0.83 |
| ▸ | POLR1C | O15160 | 1/20 | 0.83 |
| ▸ | OGT | O15294 | 1/20 | 0.83 |
| ▸ | PPM1G | O15355 | 1/20 | 0.83 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16774047 | 1.00 | BRD4 (0.83) | BRD4SMCHD1MYO1GAIPAP3B1 | |
| SCHEMBL16774026 | 1.00 | BRD4 (0.83) | BRD4SMCHD1MYO1GAIPAP3B1 | |
| SCHEMBL16773952 | 1.00 | BRD4 (0.83) | BRD4SMCHD1MYO1GAIPAP3B1 | |
| SCHEMBL16774020 | 0.99 | BRD4 (0.85) | BRD4SMCHD1MYO1GAIPAP3B1 | |
| SCHEMBL16773954 | 0.97 | BRD4 (0.79) | BRD4SMCHD1MYO1GAIPAP3B1 | |
| SCHEMBL15981875 | 0.97 | BRD4 (0.81) | BRD4SMCHD1MYO1GAIPAP3B1 | |
| SCHEMBL15981838 | 0.97 | BRD4 (0.83) | BRD4SMCHD1MYO1GAIPAP3B1 | |
| SCHEMBL25220075 | 0.96 | BRD4 (0.78) | BRD4SMCHD1MYO1GAIPAP3B1 | |
| SCHEMBL25273351 | 0.95 | BRD4 (0.76) | BRD4SMCHD1MYO1GAIPAP3B1 | |
| SCHEMBL14757284 | 0.95 | BRD4 (0.79) | BRD4SMCHD1MYO1GAIPAP3B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015081284-A1 | BIVALENT BROMODOMAIN LIGANDS, AND METHODS OF USING SAME | COFERON, INC. (US) | 2015-06-04 | — | — | WO | disclosed |
| US-20150051392-A1 | FUNCTIONALISATION OF CAGE AMINE LIGANDS FOR METALLO-RADIOPHARMACEUTICALS | THE UNIVERSITY OF MELBOURNE (AU) | 2015-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150051392-A1 | FUNCTIONALISATION OF CAGE AMINE LIGANDS FOR METALLO-RADIOPHARMACEUTICALS | SLC39A14, AOC1, RNF168 | BRD4 510/4885SMCHD1 3790/4885MYO1G 1818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.